Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Intrathecal Rituximab in Patients With Recurrent CNS Lymphoma

NCT00416923 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00416923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00416923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Intrathecal Rituximab in Patients With Recurrent CNS Lymphoma
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2002
Completion date
April 30, 2007
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, lymphoma